Controversy is in the mix after two mail-order prescription surveys with conflicting results were released within two days of each other.
The Joint Commission is targeting patient safety failures with a new program that will directly affect pharmacy operations.
GlaxoSmithKline has announced that the FDA's Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix, the company's candidate cervical cancer vaccine.
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.
The term "cardiometabolic disorders" (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists.
Want to see fear on the face of a pharmacist? Ask for a quick dosage conversion for a 75-year-old woman with breast cancer who has become too weak to swallow MS Contin tablets and needs an oral liquid morphine. Keep reading to learn more about making conversions easier.
The U.S. Food and Drug Administration published two rules recently to help clarify how very ill patients can obtain access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and have no other satisfactory treatment options.
Commercial medication therapy management programs are gaining in strength and popularity for medical, financial, and practical reasons. In Minnesota, a pilot program for state employees was so successful that two years later it expanded into a program for all fully insured members. Another program is in use by Minnesota Medicaid and General Mills. And in North Carolina, the Asheville Project is still going strong.
Record budget problems have pushed California to eliminate funding for the largest poison control system in the nation. Keep reading to find out about a California pharmacy's fight to keep the poison control system going.
While pharmacies have not been immune to the downturn in the U.S. economy, the overall picture does not appear to be one of gloom and doom. For an update on aspects of the big picture for pharmacy, read on.